Your browser doesn't support javascript.
loading
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon, Elsa; Lefeuvre-Plesse, Claudia; Martinez, Alejandra; Chauleur, Céline; Lortholary, Alain; Favier, Laure; Bats, Anne-Sophie; Guille, Arnaud; AdélaÏde, José; Finetti, Pascal; de Casteljac, Victoire; Provansal, Magali; Mamessier, Emilie; Bertucci, François; Ray-Coquard, Isabelle; Sabatier, Renaud.
Afiliação
  • Nigon E; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.
  • Lefeuvre-Plesse C; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Martinez A; Department of Surgical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
  • Chauleur C; Department of Medical Oncology, Institut de Cancérologie de la Loire, Saint Etienne, France.
  • Lortholary A; Hôpital privé du Confluent, Institut de Cancérologie Catherine de Sienne, Nantes, France.
  • Favier L; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Bats AS; Department of Surgical Oncology, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Guille A; CRCM, Predictive Oncology laboratory, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • AdélaÏde J; CRCM, Predictive Oncology laboratory, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Finetti P; CRCM, Predictive Oncology laboratory, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • de Casteljac V; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.
  • Provansal M; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.
  • Mamessier E; CRCM, Predictive Oncology laboratory, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Bertucci F; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.
  • Ray-Coquard I; CRCM, Predictive Oncology laboratory, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France.
  • Sabatier R; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon 1, Lyon, France.
J Transl Med ; 21(1): 408, 2023 06 23.
Article em En | MEDLINE | ID: mdl-37353806
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França